Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[ApoE polymorphisms and dopaminergic replacement therapy in Parkinson's disease].

Revista medica del Instituto Mexicano del Seguro Social - 1 Jan 2000

Cervantes-Arriaga Amin, Rodríguez-Violante Mayela, González-Latapí Paulina, Dávila-Ortiz de Montellano David José, Yescas Petra, Alonso-Vilatela Elisa

Abstract excerpt

BACKGROUND: The expression of apolipoprotein E (apoE) polymorphisms has been proposed as a risk factor for early development of psychotic symptoms in patients with Parkinson's disease. The association between apoE polymorphisms and motor complications is controversial. The aim was to determine the association between apoE polymorphisms and its allele frequency with the development of complications secondary to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Dopamine Agents

Share to Dyskinesias

Share to Parkinson Disease

Share to Psychotic Disorders

Share to Treatment Outcome

Source

Identifiers

PMID: 24625478

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[ApoE polymorphisms and dopaminergic replacement therapy in Parkinson's disease].PMID 24625478Read ↗

Serum Apo Lipoprotein E, Apo Lipoprotein E Gene Polymorphisms, and Parkinson's Disease.Semantic proximity Read ↗

The genetic association between apolipoprotein E gene polymorphism and Parkinson diseaseSemantic proximity Read ↗

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease.Semantic proximity Read ↗

A large study reveals no association between APOE and Parkinson's disease.Semantic proximity Read ↗

The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia.Semantic proximity Read ↗

Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.Semantic proximity Read ↗

Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.Semantic proximity Read ↗

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.Semantic proximity Read ↗

Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease.Semantic proximity Read ↗

Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease.Semantic proximity Read ↗

Apolipoprotein E genotypes and the risk of Parkinson disease.Semantic proximity Read ↗

Association analyses of Apolipoprotein E genotypes and cognitive performance in patients with Parkinson’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.